US 7456203
Muscarinic receptor antagonists
granted A61KA61K31/40
Quick answer
US patent 7456203 (Muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/40